GlassScriptPhysician profile
Norman M Lee
NPI 1144678228
$658.53
in general payments reported to CMS, 2019-2025
10 companies · $247 in 2025
The $247 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $30.00 · 2022: $125 · 2023: $84.01 · 2024: $16.64 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $141.63 | 2022-2024 | |
| Novo Nordisk INC | $141.42 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $124.91 | 2025 | Fasenra |
| Merck Sharp & Dohme LLC | $122.31 | 2025 | Keytruda |
| Merz North America, INC. | $30.00 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.23 | 2023 | Ofev |
| Grifols USA, LLC | $22.34 | 2023 | Prolastin-C Liquid |
| United Therapeutics Corporation | $22.29 | 2023 | |
| Pfizer INC. | $14.25 | 2019 | |
| Philips North America LLC | $14.15 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.